+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 65Years - 100Years
All Genders
Healthy Volunteers
ID05514405

Comparing Remimazolam and Propofol Effects on Postoperative Delirium and Recovery in Older Adults Having Hip or Knee Surgery

Led by Inje University · Updated on 2026-03-27

82

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of two anesthesia drugs, remimazolam and propofol, on elderly patients undergoing hip or knee surgery. The study focuses on comparing the occurrence of postoperative delirium and recovery quality in this population. Remimazolam is a fast-acting benzodiazepine that is preferred for older patients due to its rapid metabolism and hemodynamic stability, but its impact on postoperative delirium is not yet studied compared to propofol. Participants are randomly assigned to receive either remimazolam or propofol during surgery. Remimazolam is given starting at 6 mgkghr during anesthesia induction, then continued at 1 mgkghr within a range of 0.3 to 2 mgkghr, and stopped 20 minutes before the surgery ends. Propofol is continuously infused at 1 to 5 cgmL, with dosing guided by bispectral index monitoring to maintain anesthesia depth. During the study, researchers monitor patients for delirium up to 3 days after surgery and assess recovery quality using the QoR-15 questionnaire. Safety and drug effects are carefully observed, including hemodynamic stability. The total participation period includes the hospitalization and the 3-day postoperative observation. The study is sponsored by Inje University and uses a double-blind design to compare these anesthetic drugs in older adults undergoing orthopedic surgery.

CONDITIONS

Brief Title

Effect of Remimazolam and Propofol on Postoperative Delirium

Research Team

I

In-Jung Jun, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here